The anti-apoptotic role of PPARβ contributes to efficient skin wound healing

Journal of Steroid Biochemistry and Molecular Biology

Volumn 85, Issue 2-5, 2003, Pages 257-265

  Di Poï, Nicolas ^a   Michalik, Liliane ^a   Tan, Nguan Soon ^a   Desvergne, Béatrice ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Apoptosis; Keratinocytes; PPARs; Skin wound healing

Indexed keywords

3 PHOSPHOINOSITIDE DEPENDENT KINASE 1; DNA FRAGMENT; ENZYME; GROWTH FACTOR; INTEGRIN LINKED KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN KINASE B; RECEPTOR SUBUNIT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; EPIDERMIS; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN INJURY; TRANSCRIPTION REGULATION; WOUND HEALING;

EID: 0042388678     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00215-2     Document Type: Conference Paper

References (26)

1. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 405(6785):2000;421-424.
2. Braissant O., Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology. 139(6):1998;2748-2754.
3. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., Peters J.M., Kaya G., Gonzalez F.J., Zakany J., Metzger D., Chambon P., Duboule D., Wahli W. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J. Cell Biol. 154(4):2001;799-814.
4. Komuves L.G., Hanley K., Jiang Y., Elias P.M., Williams M.L., Feingold K.R. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J. Invest. Dermatol. 111(3):1998;429-433.
5. Peters J.M., Lee S.S., Li W., Ward J.M., Gavrilova O., Everett C., Reitman M.L., Hudson L.D., Gonzalez F.J. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20(14):2000;5119-5128.
6. Tan N.S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Fluhmann B., Desvergne B., Wahli W. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev. 15(24):2001;3263-3277.
7. Greenhalgh D.G. The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30(9):1998;1019-1030.
8. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2(7):2002;489-501.
9. Di Poi N., Tan N.S., Michalik L., Wahli W., Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell. 10(4):2002;721-733.
10. Widlak P. The DFF40/CAD endonuclease and its role in apoptosis. Acta Biochim. Pol. 47(4):2000;1037-1044.
11. Dreyer C., Keller H., Mahfoudi A., Laudet V., Krey G., Wahli W. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell. 77(1):1993;67-76.
12. Waterhouse C.C., Joseph R.R., Stadnyk A.W. Endogenous IL-1 and type II IL-1 receptor expression modulate anoikis in intestinal epithelial cells. Exp. Cell Res. 269(1):2001;109-116.
13. Vollmar B., El Gibaly A.M., Scheuer C., Strik M.W., Bruch H.P., Menger M.D. Acceleration of cutaneous wound healing by transient p53 inhibition. Lab Invest. 82(8):2002;1063-1071.
14. Tsugawa K., Jones M.K., Sugimachi K., Sarfeh I.J., Tarnawski A.S. Biological role of phosphatase PTEN in cancer and tissue injury healing. Front Biosci. 7:2002;e245-e251.
15. Grose R., Hutter C., Bloch W., Thorey I., Watt F.M., Fassler R., Brakebusch C., Werner S. A crucial role of beta 1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development. 129(9):2002;2303-2315.
16. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., Evans R.M. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 99(1):2002;303-308.
17. Chen W.S., Xu P.Z., Gottlob K., Chen M.L., Sokol K., Shiyanova T., Roninson I., Weng W., Suzuki R., Tobe K., Kadowaki T., Hay N. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15(17):2001;2203-2208.
18. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276(42):2001;38349-38352.
19. Kamei T., Jones S.R., Chapman B.M., MCGonigle K.L., Dai G., Soares M.J. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells. Mol. Endocrinol. 16(7):2002;1469-1481.
20. Bi L., Okabe I., Bernard D.J., Wynshaw-Boris A., Nussbaum R.L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J. Biol. Chem. 274(16):1999;10963-10968.
21. Lawlor M.A., Mora A., Ashby P.R., Williams M.R., Murray-Tait V., Malone L., Prescott A.R., Lucocq J.M., Alessi D.R. Essential role of PDK1 in regulating cell size and development in mice. EMBO J. 21(14):2002;3728-3738.
22. Stiles B., Gilman V., Khanzenzon N., Lesche R., Li A., Qiao R., Liu X., Wu H. Essential role of AKT-1/protein kinase B{alpha} in PTEN-controlled tumorigenesis. Mol. Cell. Biol. 22(11):2002;3842-3851.
23. Rivier M., Safonova I., Lebrun P., Griffiths C.E., Ailhaud G., Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J. Invest. Dermatol. 111(6):1998;1116-1121.
24. Takahashi H., Manabe A., Ishida-Yamamoto A., Hashimoto Y., Iizuka H. Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J. Dermatol. Sci. 28(3):2002;187-197.
25. Park B.H., Breyer B., He T.C. Peroxisome proliferator-activated receptors: roles in tumorigenesis and chemoprevention in human cancer. Curr. Opin. Oncol. 13(1):2001;78-83.
26. Park B.H., Vogelstein B., Kinzler K.W. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A. 98(5):2001;2598-2603.